Oncovista Innovative Therapies Inc logo

OVIT - Oncovista Innovative Therapies Inc Share Price

$0.026 0.0  70.4%

Last Trade - 02/07/20

Sector
Healthcare
Size
Micro Cap
Market Cap £489k
Enterprise Value £1.72m
Revenue £n/a
Position in Universe th / 6346
Bullish
Bearish
Unlock OVIT Revenue
Momentum
Relative Strength (%)
1m +40.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -42.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2015, OncoVista Innovative Therapies Inc revenues was not reported. Net loss increased 75% to $1.7M. Higher net loss reflects General and administrative increase from $419K to $1.2M (expense), Research and development increase of 21% to $483K (expense), Interest expense increase from $4K to $21K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.05 to -$0.08.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OVIT Revenue Unlock OVIT Revenue

Net Income

OVIT Net Income Unlock OVIT Revenue

Normalised EPS

OVIT Normalised EPS Unlock OVIT Revenue

PE Ratio Range

OVIT PE Ratio Range Unlock OVIT Revenue

Dividend Yield Range

OVIT Dividend Yield Range Unlock OVIT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OVIT EPS Forecasts Unlock OVIT Revenue
Profile Summary

OncoVista Innovative Therapies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The Company's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The Company's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The Company's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.

Directors
Last Annual December 31st, 2014
Last Interim September 30th, 2015
Incorporated January 8, 1999
Public Since March 10, 1998
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OTC Markets Group
Shares in Issue 23,558,530
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OVIT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OVIT
Upcoming Events for OVIT
Frequently Asked Questions for Oncovista Innovative Therapies Inc
What is the Oncovista Innovative Therapies Inc share price?

As of 02/07/20, shares in Oncovista Innovative Therapies Inc are trading at $0.026, giving the company a market capitalisation of £489k. This share price information is delayed by 15 minutes.

How has the Oncovista Innovative Therapies Inc share price performed this year?

Shares in Oncovista Innovative Therapies Inc are currently trading at $0.026 and the price has moved by -30% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Oncovista Innovative Therapies Inc price has moved by -28.87% over the past year.

What are the analyst and broker recommendations for Oncovista Innovative Therapies Inc?

There are no analysts currently covering Oncovista Innovative Therapies Inc.

When will Oncovista Innovative Therapies Inc next release its financial results?

Oncovista Innovative Therapies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-09-30
What is the Oncovista Innovative Therapies Inc dividend yield?

Oncovista Innovative Therapies Inc does not currently pay a dividend.

Does Oncovista Innovative Therapies Inc pay a dividend?

Oncovista Innovative Therapies Inc does not currently pay a dividend.

When does Oncovista Innovative Therapies Inc next pay dividends?

Oncovista Innovative Therapies Inc does not currently pay a dividend.

How do I buy Oncovista Innovative Therapies Inc shares?

To buy shares in Oncovista Innovative Therapies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Oncovista Innovative Therapies Inc?

Shares in Oncovista Innovative Therapies Inc are currently trading at $0.026, giving the company a market capitalisation of £489k.

Where are Oncovista Innovative Therapies Inc shares listed? Where are Oncovista Innovative Therapies Inc shares listed?

Here are the trading details for Oncovista Innovative Therapies Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: OVIT
What kind of share is Oncovista Innovative Therapies Inc?

We were not able to load our ranking data for Oncovista Innovative Therapies Inc

Is there a Oncovista Innovative Therapies Inc share price forecast 2020?

We were not able to load any forecast data for Oncovista Innovative Therapies Inc.

How can I tell whether the Oncovista Innovative Therapies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oncovista Innovative Therapies Inc. Over the past six months, the relative strength of its shares against the market has been 86.79%. At the current price of $0.026, shares in Oncovista Innovative Therapies Inc are trading at 12.42% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Oncovista Innovative Therapies Inc PE Ratio?

We were not able to find PE ratio data for Oncovista Innovative Therapies Inc.

Who are the key directors of Oncovista Innovative Therapies Inc?

Oncovista Innovative Therapies Inc's management team is headed by:

Alexander Weis - CHM
Who are the major shareholders of Oncovista Innovative Therapies Inc?

Here are the top five shareholders of Oncovista Innovative Therapies Inc based on the size of their shareholding:

Osborn Williams & Donohoe LLC Investment Advisor
Percentage owned: % (n/a shares)
Simmons First Trust Company N.A. Bank and Trust
Percentage owned: % (n/a shares)
Similar to OVIT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.